WASHINGTON--(BUSINESS WIRE)--Finkelstein Thompson LLP is investigating potential claims on behalf of shareholders of Allied Defense Group Inc. ("ADG" or the "Company") (NYSE Amex:ADG) arising from the Company's announcement of its intent to be acquired by Chemring Group PLC ("Chemring").

On January 19, 2010, ADG announced its plan to merge with Chemring. Under the terms of the merger agreement, ADG shareholders will receive $7.25 in cash for every share of ADG common stock they own in a transaction valued at $59 million.

The investigation is focused on the potential unfairness of the consideration to be paid to ADG shareholders as well as the potential unfairness of the process by which the ADG Board of Directors is addressing the transaction.

If you are interested in discussing your rights as an ADG shareholder, or have information relating to this investigation, please contact Finkelstein Thompson's Washington, DC offices at (877) 337-1050 or by email at  This email address is being protected from spam bots, you need Javascript enabled to view it .